Red Cat Holdings enters its July 27 earnings report in a genuinely unusual position: short sellers have been adding to positions for a month straight, the borrow market is completely locked, and options traders are positioning more bullishly than at almost any point in the past year — all while the stock trades 25% below where it was thirty days ago.
The borrow picture is as tight as it gets. Availability has been at or near zero for most of July, meaning the lending pool is fully tapped — every share available to borrow is already out on loan. That compares to availability above 30% as recently as mid-June, a compression that happened over about three weeks. Short interest has risen alongside it, climbing 22% over the past month to reach nearly 29% of the free float. Borrowing costs, at around 1.4%, remain modest in absolute terms — so while the squeeze mechanics are present in the structure, the cost signal isn't yet flashing distress. Days to cover is 2.6 by the most recent official FINRA reading, which limits the fuel available for a disorderly unwind. The ORTEX short score sits at 70, a level it has been grinding toward steadily over the past two weeks, and the stock ranks in the bottom 3% of the universe on short score — the combination of high short interest, full borrow usage, and weak recent momentum.
Options traders are telling a different story. The put/call ratio has fallen to 0.34, nearly two standard deviations below its 20-day average of 0.41 — a rare divergence that puts current call demand well above historical norms. The ratio is approaching the 52-week low of 0.23, suggesting options buyers are positioned for upside rather than protection into earnings. That sits awkwardly against the short interest structure: one cohort is hedging aggressively short via the stock borrow market, another is buying calls. The two signals diverge sharply, which makes the July 27 print a genuine catalyst in either direction.
The Street is uniformly bullish on paper, though the analyst data carries some age. All five covering analysts have Buy ratings, with a consensus price target near $22 — roughly 156% above the current $8.59 close. Roth Capital initiated with a $25 Buy in early June, and HC Wainwright started at $20 in late May. Neither firm is a bulge bracket, but both initiations are recent enough to carry weight. The bull case rests on a strong drone and unmanned systems product portfolio, expanding defense contracts, and reported sales growth of over 300% year-on-year. The bear case is straightforward: execution risk on scaling the SRR2 program, dependence on key suppliers, and the unpredictability of defense spending cycles. The stock's EPS surprise factor scores at the 99th percentile — RCAT has a strong history of beating estimates — but near-term EPS momentum has turned negative, ranking in just the 11th percentile over the past 30 days. The price-to-book multiple has compressed sharply, down 0.75 turns over the past month.
Insider activity adds a cautionary note. Founder and CEO Jeffrey Thompson sold 150,000 shares on July 15 at $8.51, realising $1.28 million. Director Paul Funk sold 165,000 shares in mid-June at $11.50, a $1.9 million exit. Both sales occurred into stock weakness. The 90-day net insider position is technically positive in share terms due to several stock awards, but the two open-market sales from the CEO and a director in the past six weeks represent the clearest discretionary signal. BlackRock added 2.8 million shares as of June 30, and State Street added over 4.4 million — major passive accumulation that provides a counterweight, but passive flows don't speak to conviction the way a C-suite purchase would.
The earnings reaction history is also worth noting. The June 18 print saw the stock fall 5% on the day and 20% over the following week. The May 7 result produced a 2.4% next-day drop and an 8% five-day loss. Three of the last four reported events have been followed by meaningful declines over the week that followed. Whether July 27 breaks that pattern is what the competing signals — a fully tapped borrow market, a bullishly skewed options book, and analyst targets implying more than double the current price — will ultimately determine.
See the live data behind this article on ORTEX.
Open RCAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
